Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
0.00%
NET PROFIT MARGIN AVG 15Y
0.00%
NET PROFIT MARGIN AVG 20Y
0.00%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
SELLAS Life Sciences Group, Inc.
Market Cap
$2.11B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.11B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.11B
Net Profit Margin
7.13%
TTM Avg
6.55%
3Y Avg
5.96%
5Y Avg
5.57%
Market Cap
$2.13B
Net Profit Margin
-23.40%
TTM Avg
-11.02%
3Y Avg
-85.68%
5Y Avg
-98.82%
Market Cap
$2.08B
Net Profit Margin
-36.51%
TTM Avg
-21.30%
3Y Avg
-316.14%
5Y Avg
-299.31%
Market Cap
$2.06B
Net Profit Margin
-544.06%
TTM Avg
-44935.33%
3Y Avg
-43227.84%
5Y Avg
-31022.63%
Market Cap
$2.06B
Net Profit Margin
-268385.71%
TTM Avg
-9751.05%
3Y Avg
-6580.61%
5Y Avg
-4774.06%
Market Cap
$2.17B
Net Profit Margin
-37.07%
TTM Avg
-63.15%
3Y Avg
-35.64%
5Y Avg
-15.45%
Market Cap
$2.05B
Net Profit Margin
7.91%
TTM Avg
5.18%
3Y Avg
-0.36%
5Y Avg
-0.65%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | $2.11B | 0.00% | 0.00% | 0.00% | 0.00% |
| Vera Therapeutics, Inc. (VERA)vs › | $2.11B | 0.00% | 0.00% | 0.00% | 0.00% |
| Addus HomeCare Corporation (ADUS)vs › | $2.11B | 7.13% | 6.55% | 5.96% | 5.57% |
| GeneDx Holdings Corp. (WGS)vs › | $2.13B | -23.40% | -11.02% | -85.68% | -98.82% |
| Alvotech (ALVO)vs › | $2.08B | -36.51% | -21.30% | -316.14% | -299.31% |
| Viridian Therapeutics, Inc. (VRDN)vs › | $2.06B | -544.06% | -44935.33% | -43227.84% | -31022.63% |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.06B | -268385.71% | -9751.05% | -6580.61% | -4774.06% |
| Maravai LifeSciences Holdings, Inc. (MRVI)vs › | $2.17B | -37.07% | -63.15% | -35.64% | -15.45% |
| Vericel Corporation (VCEL)vs › | $2.05B | 7.91% | 5.18% | -0.36% | -0.65% |
| Pharvaris N.V. (PHVS)vs › | $2.17B | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | -1674.40% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | -242.79% |
| 2021-03-31 | -42.16% |
| 2020-12-31 | -195.58% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 320.91% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | -463.04% |
| 2015-03-31 | -383.16% |
| 2014-12-31 | -249.01% |
| 2014-09-30 | -381.05% |
| 2014-06-30 | -855.47% |
| 2014-03-31 | -116.71% |
| 2013-12-31 | -3682.69% |
| 2013-09-30 | -793.76% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | -182.53% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | -753.50% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
